Syncope
Syncope: classify the mechanism, exclude cardiac causes, counsel on driving
Syncope is a brief self-terminating loss of consciousness from global cerebral hypoperfusion. Main mechanisms: reflex/vasovagal (~60%), orthostatic hypotension (~15%), cardiac arrhythmia or structural disease (~10%).
Cardiac syncope (up to 30% one-year mortality untreated) must be excluded first. Red flags for same-day assessment: exertional syncope, onset from sitting or supine, abnormal ECG, preceding chest pain or palpitations, or family history of sudden cardiac death under 40.
Vasovagal syncope: education, hydration, salt, and counter-pressure manoeuvres. Document Austroads 2022 driving restrictions at every relevant visit.
Syncope is a transient, self-terminating loss of consciousness caused by global cerebral hypoperfusion, with a rapid onset, short duration, and complete spontaneous recovery. This definition excludes seizure, psychogenic pseudosyncope, hypoglycaemia, intoxication, and head trauma — all of which cause altered consciousness through different mechanisms with different implications.
Lifetime prevalence is approximately 35% in the general population. Syncope accounts for around 3% of Australian emergency department presentations and approximately 6% of hospital admissions in older adults. In those aged over 75, approximately one in ten people experiences at least one syncopal episode per year. The clinical challenge is not confirming that syncope occurred — the history is usually sufficient — but reliably excluding cardiac causes, which carry up to 30% one-year mortality without treatment, before reassigning the label of vasovagal.
The ESC 2018 syncope guideline — used here because no current national Australian syncope-specific guideline exists — classifies syncope by mechanism into three groups: reflex (neurally mediated), orthostatic hypotension, and cardiac. eTG and the RACGP align with this framework for Australian general practice.
A. Core clinical — the AU general-practice framework
Mechanism-based classification
Reflex (neurally mediated) syncope results from an inappropriate autonomic reflex causing sudden vasodilatation, bradycardia, or both — accounting for approximately 60% of all syncope presentations. Subtypes:
- Vasovagal — the commonest; triggered by prolonged standing, pain, heat, blood or needle procedures, emotional distress; prodrome of nausea, sweating, heat, and darkening vision
- Situational — triggered by coughing, micturition, defaecation, or swallowing
- Carotid sinus syndrome — head turning or tight collar; relevant predominantly in older adults
Orthostatic hypotension — failure of compensatory vasoconstriction on standing, producing a systolic BP drop ≥20 mmHg or diastolic BP drop ≥10 mmHg within 3 minutes of standing. Common causes in general practice:
- Drug-induced — the single most common and most correctable cause; antihypertensives, α-blockers (tamsulosin, prazosin), diuretics, tricyclic antidepressants, antiparkinsonian agents, antipsychotics
- Volume depletion — diarrhoea, vomiting, poor fluid intake, diuretic overuse
- Neurogenic — Parkinson’s disease, multiple system atrophy, diabetic autonomic neuropathy, amyloidosis
Cardiac syncope — either arrhythmic or structural:
- Arrhythmic — AV block (any degree), sick sinus syndrome, ventricular tachycardia, SVT, torsades de pointes (QT prolongation), AF with very rapid ventricular rates
- Structural — severe aortic stenosis, hypertrophic cardiomyopathy (HCM), massive pulmonary embolism, acute myocardial infarction, cardiac tamponade, atrial myxoma
Red flags requiring same-day hospital assessment
- Exertional syncope — assume cardiac until proven otherwise (HCM, severe aortic stenosis, anomalous coronary artery, arrhythmia, PE)
- Syncope from supine or sitting position — never reflex or orthostatic; always cardiac
- Abnormal 12-lead ECG — AV block, prolonged QT interval (>500 ms), Brugada pattern (RBBB + ST elevation V1–V2), pre-excitation (delta wave), T-wave inversions in anterior leads, bundle branch block, ischaemia
- Chest pain, dyspnoea, or palpitations preceding the episode — suggest ACS, PE, or arrhythmia
- Family history of sudden cardiac death before age 40 — channelopathy or cardiomyopathy
- Severe injury from the syncopal fall, or high-risk occupation (commercial driver, airline pilot, working at heights)
History — the most powerful diagnostic tool
Obtain a witness account wherever possible. The event characteristics are highly discriminating:
Pre-event: position at onset (upright = vasovagal/orthostatic; supine = cardiac), trigger, prodrome quality and duration (vasovagal prodrome lasts seconds to minutes; cardiac syncope has no warning or very brief palpitations).
Event: duration (vasovagal seconds; cardiac brief; seizure 1–2 minutes); limb movements (anoxic jerks — brief, asynchronous — are common in syncope and do not indicate seizure; sustained tonic-clonic activity >30 seconds indicates seizure); lateral tongue biting; eye position (eyes usually open and upward in syncope; closed in psychogenic pseudosyncope).
Post-event: rapid complete recovery within seconds to a minute (syncope) versus prolonged confusion or fatigue persisting minutes to hours (seizure or cardiac stunning).
Drug history is mandatory in every syncope assessment — systematic review of every antihypertensive, alpha-blocker, QT-prolonging agent (sotalol, amiodarone, methadone, macrolides, fluoroquinolones, antipsychotics, high-dose citalopram), and new prescription.
Examination
Orthostatic blood pressure is measured lying then at 1 and 3 minutes standing with simultaneous heart rate. A drop of ≥20 mmHg systolic or ≥10 mmHg diastolic, or symptomatic drop at any magnitude within 3 minutes, confirms orthostatic hypotension. Immediate orthostatic hypotension (within 15 seconds) is a distinct variant relevant in autonomic failure.
Cardiac examination: murmurs (aortic stenosis — ejection systolic with quiet S2, slow-rising pulse; HCM — systolic murmur increased with Valsalva), presence of S3 or raised JVP. Carotid sinus massage is performed only by trained clinicians with monitoring equipment available.
Investigations
A 12-lead ECG is mandatory in every syncope assessment (item 11707 on MBS). Interpret specifically for: AV block, QRS duration over 120 ms, QT interval (Bazett-corrected >500 ms male, >480 ms female), Brugada pattern, epsilon wave (ARVC), delta waves (pre-excitation/WPW), anterior T-wave inversions, inferior Q waves, left bundle branch block.
Bloods: FBC, electrolytes, creatinine, glucose, HCG in women of reproductive age; troponin and BNP if cardiac features; D-dimer if PE is on the differential.
Risk stratification: the Canadian Syncope Risk Score (Thiruganasambandamoorthy CMAJ 2016) predicts 30-day serious adverse events using 9 variables including ECG abnormalities, vasovagal predisposition, troponin, and blood pressure. Score ≥1 warrants further evaluation.
Second-line (specialist-ordered): echocardiogram when structural disease is suspected; ambulatory ECG monitoring for recurrent unexplained syncope (Holter 24–72h, patch monitor 7–14 days, implantable loop recorder for prolonged monitoring); tilt-table test to confirm mechanism in equivocal cases; exercise stress test for exertional syncope.
B. Evidence appraisal — what works for vasovagal and orthostatic syncope
Non-pharmacological management of vasovagal syncope
First-line treatment for vasovagal syncope is education, reassurance, and physical countermeasures. Krediet et al. (Circulation 2002) demonstrated that counter-pressure manoeuvres — leg crossing with simultaneous thigh and calf tensing, or wrist tensing — aborted impending syncope in approximately 60% of patients who had a prodrome. This is now standard first-line advice per ESC 2018.
Salt intake of 8–10 g/day (if not hypertensive or fluid-restricted) and fluid intake of 2.5–3 L/day provide volume expansion. Trigger avoidance, physical conditioning, and tilt training (progressive standing against a wall) complement these measures.
Beta-blockers for vasovagal syncope
The POST trial (Circulation 2006) demonstrated clearly that beta-blockers provide no benefit for vasovagal syncope in patients under 42 years. They are not routinely recommended and should be avoided in young patients with vasovagal syncope.
Pharmacotherapy when conservative measures fail
Midodrine (α-1 agonist, 2.5–10 mg three times daily) is the most evidence-supported pharmacological option for refractory vasovagal syncope and orthostatic hypotension. Fludrocortisone (0.05–0.2 mg daily) provides modest mineralocorticoid effect — potassium and blood pressure monitoring required.
For POTS, Taub et al. (JACC 2021) showed ivabradine — an If channel inhibitor lowering heart rate without negative inotropic effect — produced significant symptom improvement in a randomised controlled trial. Ivabradine for POTS is off-label in Australia and privately funded.
Pacemaker for cardioinhibitory vasovagal
The BIOSync trial (EHJ 2021) demonstrated a significant reduction in syncope recurrence with dual-chamber closed-loop pacing in patients over 40 years with documented cardioinhibitory vasovagal syncope (asystole >3 seconds on implantable loop recorder during spontaneous episode). This is a Class IIa recommendation — specialist-initiated in selected refractory patients who have failed conservative and pharmacological management.
C. Driving and medico-legal obligations
Driving counselling is the most frequently omitted but legally mandatory element of syncope management. Under Austroads 2022 — Assessing Fitness to Drive, the standards are:
| Syncope type | Private licence | Commercial licence |
|---|---|---|
| Single vasovagal (clear cause, low risk) | No restriction | 4 weeks symptom-free |
| Recurrent vasovagal | 4 weeks event-free if conservative measures effective | 6 months event-free |
| Unexplained or suspected cardiac | Not fit until evaluation complete | Strict criteria; specialist input required |
| Post-pacemaker insertion | 2 weeks | 4 weeks |
| Post-ICD shock | 6 months | Not fit (usually permanently) |
Document this discussion explicitly in the medical record, including the patient’s acknowledgement of the restriction and the plan for review. Failure to document exposes the treating clinician to significant legal risk if the patient drives during a restricted period and causes harm. Commercial drivers with unexplained syncope may require reporting under state and territory regulations.
Additional safety counselling: avoid swimming alone, working at heights, operating unguarded machinery, or other activities where transient loss of consciousness would cause serious injury.
D. Australian operations
MBS items
For syncope assessment in general practice (MBS Online):
- GP consultations: items 23, 36, 44 (Level B/C/D)
- ECG: item 11707
- 24-hour ambulatory ECG (Holter): item 11709 (specialist-ordered)
- Tilt-table test: item 11724 (specialist-administered)
- Echocardiogram (specialist): item 55126
- Implantable loop recorder insertion: item 38338 range (specialist)
- GPCCMP for chronic/recurrent syncope management: items 965/967
- ATSI Health Assessment: item 715
PBS prescribing
Under the Pharmaceutical Benefits Scheme and per AMH:
- Midodrine — Authority Required (Streamlined) for orthostatic hypotension or vasovagal syncope after non-pharmacological measures have been tried
- Fludrocortisone — Authority Required for adrenocortical insufficiency; orthostatic hypotension use is off-label (patient self-funded for this indication in most cases)
- Ivabradine — Authority Required for heart failure (HFrEF); POTS use is off-label and privately funded
- Beta-blockers — General Schedule
Mental Health Care Plan relevance
Anxiety commonly coexists with vasovagal syncope and POTS. Psychogenic pseudosyncope — frequent collapse without haemodynamic change or ECG abnormality — responds to psychology and is appropriately referred via Better Access (MHCP items 2715/2717).
E. Special populations
Older adults
Syncope in older adults most commonly results from drug-induced orthostatic hypotension, cardiac arrhythmia, or carotid sinus syndrome. Drug review is the single highest-yield intervention — systematically evaluate every antihypertensive, diuretic, and alpha-blocker. Falls risk assessment per RACGP guidelines and occupational therapy input for home hazard modification are standard care. Avoid over-investigating obvious vasovagal while equally avoiding under-investigation of cardiac causes.
Children and adolescents
Vasovagal syncope is overwhelmingly the most common cause in this age group, typically after prolonged standing at school assemblies, in warm environments, or during blood tests. Reassurance and education are the mainstay. Cardiac causes — HCM and inherited channelopathies (long QT syndrome, Brugada syndrome) — are rare but important and can present with exertional syncope or sudden cardiac death. ECG and family history screening are essential for any syncopal event during exertion or in a child with family history of young sudden death.
Pregnancy
Orthostatic hypotension is common in pregnancy, particularly the second trimester, due to reduced systemic vascular resistance. Position-related syncope in late pregnancy when supine — from aortocaval compression — is a distinct phenomenon managed by lying on the left side. Adequate hydration is important. Vasovagal syncope also increases in frequency during pregnancy, particularly during blood draws and procedures. Cardiac causes should still be excluded if features are atypical.
POTS
POTS affects predominantly women aged 20–40 and has significant overlap with post-COVID-19 autonomic dysfunction, chronic fatigue, and anxiety presentations. Diagnosis requires a heart rate rise of ≥30 bpm within 10 minutes of standing (≥40 bpm in those aged 12–19) without orthostatic hypotension. POTS Australia provides peer support and consumer information. Treatment is multimodal as described above. Specialist referral (autonomic clinic, cardiology, or neurology) is appropriate for disabling or diagnostically unclear cases.
When to escalate
Same-day ED referral: any suspected cardiac syncope — exertional, from supine position, with abnormal ECG, preceding chest pain or dyspnoea, severe fall-related injury, haemodynamic instability, or focal neurology after event.
Same-week cardiology or electrophysiology referral: recurrent unexplained syncope after basic workup, family history of sudden cardiac death under 40, structural heart disease on examination or echocardiogram, suspected arrhythmia not captured on standard ECG.
Routine referral: frequent disabling vasovagal refractory to conservative management, POTS for multidisciplinary input, complex autonomic failure, suspected channelopathy or cardiomyopathy requiring genetic workup.
Neurology referral is appropriate when seizure remains in the differential after normal ECG and normal orthostatic blood pressure, particularly if the event involved sustained tonic-clonic activity, post-ictal confusion, lateral tongue bite, or witnessed eye deviation.
What this article is and is not
This is general health information based on eTG, AMH, RACGP, Austroads 2022, and the ESC 2018 syncope guideline. It is not personal medical advice and does not create a doctor–patient relationship. Individual decisions — including specialist referral, pharmacotherapy choices, and driving restrictions — are made in consultation with your GP, accounting for your full clinical history and circumstances.
For AU consumer resources: HealthDirect — Fainting, Better Health Channel — Fainting, POTS Australia, Heart Foundation.
Sources cited
- Therapeutic Guidelines (eTG) — Cardiovascular: Syncope
- RACGP — Syncope assessment in general practice
- Australian Medicines Handbook (AMH)
- Austroads — Assessing Fitness to Drive 2022
- POTS Australia
- HealthDirect — Fainting
- Better Health Channel — Fainting
- Heart Foundation Australia
- Brignole M et al. ESC 2018 Guidelines for the diagnosis and management of syncope
- HRS 2015 Expert Consensus on POTS, IST and VVS
- Brignole M et al. BIOSync trial — pacemaker for vasovagal (EHJ 2021)
- Krediet CT et al. — Counter-pressure manoeuvres (Circulation 2002)
- Sheldon R et al. POST trial — beta-blocker in vasovagal syncope (Circulation 2006)
- Taub PR et al. — Ivabradine in POTS (JACC 2021)
- Thiruganasambandamoorthy V et al. Canadian Syncope Risk Score (CMAJ 2016)
Frequently asked questions
-
How do I know if my syncope is the dangerous kind?
The most important discriminators are the circumstances and a 12-lead ECG. Dangerous (cardiac) syncope typically occurs with no warning, from a sitting or lying position, during or after exertion, or accompanied by chest pain or palpitations beforehand. Common vasovagal fainting has a classic prodrome — feeling hot, nauseated, sweaty, or light-headed — triggered by prolonged standing, pain, heat, or emotional distress. A normal ECG makes dangerous arrhythmic syncope considerably less likely. Your GP will weigh all these factors together and decide whether specialist cardiac investigation is needed.
-
What is vasovagal syncope and why does it happen?
Vasovagal syncope — also called a simple faint — occurs when a reflex causes the blood vessels to dilate and sometimes the heart rate to slow simultaneously, dropping blood pressure too quickly for the brain to maintain consciousness. Common triggers include prolonged standing, heat, dehydration, blood or needle procedures, and emotional distress. It is extremely common — lifetime prevalence around 35% — and the underlying mechanism is benign, though recurrent episodes cause distress and injury risk. The key treatment is understanding triggers, staying well hydrated, and practising counter-pressure manoeuvres to abort impending episodes.
-
What are counter-pressure manoeuvres and do they actually work?
Counter-pressure manoeuvres are physical techniques performed at the first sign of an impending faint. They work by increasing venous return to the heart and raising blood pressure before consciousness is lost. The most effective are: crossing the legs and tensing the thigh and calf muscles simultaneously, gripping one hand around the opposite wrist and tensing both arms, and squatting or lying flat immediately. Research including the Krediet study in Circulation 2002 showed these manoeuvres abort syncope in approximately 60% of patients who have a prodrome. Practise them before you need them — they require some deliberate effort.
-
Do I need to stop driving after a faint?
It depends on the type and circumstances. Under Austroads 2022 fitness-to-drive standards, a single vasovagal faint with a clear identifiable cause and no cardiac concerns generally carries no restriction for private car licence holders. Commercial (heavy vehicle, bus) licence holders need 4 weeks symptom-free. Recurrent vasovagal syncope means 4 weeks event-free for private and 6 months for commercial licences. Unexplained or suspected cardiac syncope means not fit to drive until full evaluation is complete. Your GP is required to document this conversation. Always confirm your status with your GP before returning to driving.
-
What is POTS and how is it treated?
POTS (postural orthostatic tachycardia syndrome) is a condition where heart rate rises by 30 or more beats per minute within 10 minutes of standing, without a significant fall in blood pressure. It is most common in young women and causes dizziness, fatigue, palpitations, brain fog, and near-fainting on standing. First-line treatment is high fluid intake (3 litres daily), salt supplementation (8–10 grams daily), graduated upright conditioning exercises starting in recumbent positions (swimming, rowing), and compression garments. Low-dose beta-blocker or ivabradine may be added if lifestyle measures are insufficient. Specialist autonomic clinic referral is appropriate for disabling cases.
-
Is syncope ever related to a heart rhythm problem?
Yes — cardiac arrhythmia is the cause of syncope in approximately 10% of cases and is the most dangerous mechanism. Slow heart rhythms (bradycardia, heart block) and fast rhythms (ventricular tachycardia, atrial fibrillation with very fast rates) both reduce cardiac output enough to cause brief loss of consciousness. Unlike vasovagal fainting, arrhythmic syncope typically has no prodrome, occurs from any position including lying down, and recovers immediately. A 12-lead ECG is mandatory in all syncope assessments, and any abnormal finding — AV block, long QT interval, Brugada pattern, or pre-excitation — warrants urgent cardiology referral.
Source quality
Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.
-
T1 AU primary 8 sources -
T2 International primary 2 sources -
T3 Named-author reconstruction 5 sources - Brignole M et al. BIOSync trial — pacemaker for vasovagal (EHJ 2021)
- Krediet CT et al. — Counter-pressure manoeuvres (Circulation 2002)
- Sheldon R et al. POST trial — beta-blocker in vasovagal (Circulation 2006)
- Taub PR et al. — Ivabradine for POTS (JACC 2021)
- Thiruganasambandamoorthy V et al. Canadian Syncope Risk Score (CMAJ 2016)